Novel Drug Impresses in Metastatic Pancreatic Cancer
(MedPage Today) -- SAN DIEGO -- Two phase I/II studies showed that the investigational RAS(ON) inhibitor daraxonrasib had a manageable ...
(MedPage Today) -- SAN DIEGO -- Two phase I/II studies showed that the investigational RAS(ON) inhibitor daraxonrasib had a manageable ...
(MedPage Today) -- Note that some links may require registration or subscription. Todd Lyons, the acting head of Immigration and ...
(MedPage Today) -- SAN FRANCISCO -- Adding modified FOLFOX6 (oxaliplatin, leucovorin, and fluorouracil) and bevacizumab (Avastin) to atezolizumab (Tecentriq) significantly ...
© 2025 PickByDoc. All rights reserved. PickByDoc is a medical news & health awareness platform.